Fintl C, Ihler C F
Norwegian School of Veterinary Science, Department of Companion Animal Clinical Sciences, Norway.
Equine Vet J Suppl. 2011 Aug(39):149-52. doi: 10.1111/j.2042-3306.2011.00374.x.
D(+)-xylose absorption tests are commonly performed when investigating suspected small intestinal malabsorption in the horse. The test involves the administration of a D(+)-xylose solution via a nasogastric tube followed by serial blood sampling to determine its rate of absorption. In some horses, nasogastric intubation cannot be safely performed without prior administration of a sedative. Due to its short duration of action, the α(2) agonist xylazine is commonly used for this purpose. However, α(2) agonists have also been reported to influence the rate of gastric emptying as well as small intestinal motility patterns.
To evaluate if prior sedation with xylazine would influence the rate of absorption of D(+)-xylose in 6 normal Standardbred horses in a randomised cross-over study.
D(+)-xylose was administered by nasogastric intubation at a dose rate of 0.5 g/kg bwt given as a 10% solution with water while xylazine was administered iv at a dose rate of 0.5 mg/kg bwt. A heparinised blood sample was collected prior to administration of D(+)-xylose (and xylazine when used) and then at 30, 45, 60, 75, 90, 120, 150, 180 and 240 min following administration. Samples were immediately analysed using a modified colorimetric micro method. The cumulative amount of D(+)-xylose absorbed at each time point with and without prior sedation were. The significance rate was set at P<0.05.
The study failed to demonstrate a statistically significant difference in the amount of D(+)-xylose absorbed between sedated and unsedated animals, although there was a tendency for a less rapid initial uptake with prior sedation.
This study suggests that prior sedation with xylazine will not significantly affect the result of a D(+)-xylose absorption test in the normal horse.
在调查马匹疑似小肠吸收不良时,通常会进行D(+)-木糖吸收试验。该试验包括通过鼻胃管给予D(+)-木糖溶液,随后进行系列采血以确定其吸收速率。在一些马匹中,若不预先给予镇静剂,则无法安全地进行鼻胃管插管。由于其作用持续时间短,α(2)激动剂赛拉嗪通常用于此目的。然而,也有报道称α(2)激动剂会影响胃排空速率以及小肠运动模式。
在一项随机交叉研究中,评估预先使用赛拉嗪镇静是否会影响6匹正常标准赛马D(+)-木糖的吸收速率。
通过鼻胃管以0.5 g/kg体重的剂量给予D(+)-木糖,以10%的溶液与水混合,同时以0.5 mg/kg体重的剂量静脉注射赛拉嗪。在给予D(+)-木糖(以及使用赛拉嗪时)之前采集一份肝素化血样,然后在给药后的30、45、60、75、90、120、150、180和240分钟采集血样。使用改良的比色微量法立即分析样本。记录有无预先镇静情况下每个时间点吸收的D(+)-木糖的累积量。显著性水平设定为P<0.05。
该研究未能证明镇静和未镇静动物之间吸收的D(+)-木糖量存在统计学上的显著差异,尽管预先镇静时有初始摄取不太迅速的趋势。
本研究表明,预先使用赛拉嗪镇静不会显著影响正常马匹D(+)-木糖吸收试验的结果。